MedTrace Logo

Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis

NCT02194855 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-08-12

No results posted yet for this study

Summary

The investigators investigated whether laparoscopic versus open surgical approaches affected the pharmacokinetic and pharmacodynamic of a single bolus dose of rocuronium or cisatracurium.

Conditions

  • C.Delivery; Surgery (Previous), Gynecological

Interventions

DRUG

rocuronium

Rocuronium 0.6 mg.kg-1 was administered within 5 s as an intravenous bolus

DRUG

cisatracurium

cisatracurium 0.15mg.kg-1 was administered within 5 s as an intravenous bolus

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Shaoqiang Huang, doctor · Obstetrics and Gynecology,Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2016-01-01
Completion
2016-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02194855 on ClinicalTrials.gov